Moving Cupping for Plaque Psoriasis: a Randomized Controlled Trial

Exclusion Criteria

• •1. Patients with pustular psoriasis, arthropathic, erythroderma psoriasis and / or drip psoriasis;
• •2. Plaque psoriasis patients with BSA\>10%;
• •3. Any clinically active skin diseases other than moderate to severe psoriasis vulgaris which might counter or influence the study aim;
• •4. Patients who used any of the following systemic treatments within 4 weeks before the Baseline visit e.g.: drugs for other studies, immuno-suppressive drugs, biologics;
• •5. Patients who used topical treatment within 2 weeks before the Baseline visit e.g. corticosteroids ultraviolet-light therapy including sunbathing;
• •6. Active infectious disease which was hard to control;
• •7. History of severe systemic disease. Or the clinical test index is one of the following: the ALT or the AST is higher than 1.5 times; Any of the main routine blood indexes (WBC, RBC, HB, PLT) is lower than the limit of normal; or other laboratory abnormalities and patients were judged not to be suitable for this study;
• •8. Family history of cancer-prone patients;
• •9. Patients with immunocompromised and can cause skin allergies and infection when moving cupping;
• •10. Pregnant or lactating women;
• •11. Patients with a history of alcohol abuse and drug abuse;
• •12. Have a history of serious mental illness or family history; 13 Other reasons researchers believe that patients are not suitable for this study.